TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/3/18 15:35 | 8/1/18 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lund-Jurgensen Kirsten | NY | O | EVP | S | -839 | 40.04 | 0 | -21 | -82 | 5 | D | ||||||||||||||
3/2/18 15:44 | 2/28/18 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lund-Jurgensen Kirsten | NY | O | EVP | M.d | 528 | 27.37 | 0 | 19 | 308 | 26 | D | ||||||||||||||
2/27/18 19:38 | 2/24/18 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lund-Jurgensen Kirsten | NY | O | EVP | M.d | 302 | 18.90 | 0 | 16 | 880 | 18 | D | ||||||||||||||
2/27/18 19:38 | 2/26/18 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lund-Jurgensen Kirsten | NY | O | EVP | S.d | -354 | 37.19 | 0 | -10 | -35 | 18 | D | ||||||||||||||
2/27/17 18:30 | 2/23/17 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lund-Jurgensen Kirsten | NY | O | EVP | M.d | 447 | 21.03 | 33 | 21 | 20 | D | 6 | 16 | 0 | 10 | 6 | 7 | 5 | 2 | 0 | 1 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |